Digestive Health Supplements Market Analysis by Mordor Intelligence
The digestive health supplements market is expected to reach USD 10.86 billion in 2025 and is forecast to reach USD 14.63 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.14%. Preventive health attitudes, clinical validation of microbiome interventions, and heightened global oversight are driving momentum in the market. These factors are shaping consumer preferences and pushing the industry toward higher standards. Demand is bolstered by an aging population seeking metabolic support to manage age-related health concerns, younger consumers influenced by social media, uncovering the gut-immune connection and its impact on overall well-being, and companies rolling out data-driven personalization services to cater to individual health needs. Regulatory convergence, especially with the U.S. Food and Drug Administration's surprise inspections abroad, is bridging the historical quality divide between domestic and international facilities, fostering trust in the category by ensuring consistent product standards. Concurrently, attributes like clean-label positioning and transparent sourcing have transitioned from premium perks to essential standards, compelling brands to invest in traceable supply chains and third-party verifications to meet consumer expectations and regulatory requirements.
Key Report Takeaways
- By type, probiotics led with 82.12% of the digestive health supplements market share in 2024, while enzymes are projected to expand at a 7.45% CAGR through 2030.
- By form, capsules and soft gels accounted for 47.43% share of the digestive health supplements market size in 2024; gummies and chewables register the fastest growth at 7.21% CAGR to 2030.
- By distribution channel, specialty, and health stores held a 36.23% share in 2024, whereas online retailers posted the strongest CAGR at 8.51% through 2030.
- By geography, North America captured a 42.44% share in 2024, and the Middle East and Africa region is poised for the quickest advance at 8.62% CAGR to 2030.
Global Digestive Health Supplements Market Trends and Insights
Drivers Impact Analysis
DRIVER | (~)% Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Rising incidence of gastrointestinal disorders boosts growth | +1.8% | Global, with concentration in North America and Europe | Medium term (2-4 years) |
Increasing consumer awareness of the microbiome–immune axis drives demand | +1.2% | North America and EU, expanding to Asia-Pacific | Long term (≥ 4 years) |
Integration of digestive supplements into daily nutritional regimens drives growth | +0.9% | Global, led by developed markets | Short term (≤ 2 years) |
Enhanced digestive health awareness through digital media platforms adds to its growth | +0.7% | Global, with Gen Z concentration in urban centers | Short term (≤ 2 years) |
Increasing trend for clean-label and plant-based supplement formulations | +0.6% | North America and EU, spill-over to Asia-Pacific | Medium term (2-4 years) |
Growing use of digestive aids among aging adults with slower metabolism | +0.5% | North America, Europe, Japan | Long term (≥ 4 years) |
Source: Mordor Intelligence
Rising Incidence of Gastrointestinal Disorders Boosts Growth
As functional gastrointestinal disorders rise in prevalence, supplements are transitioning from occasional remedies to staples in long-term health regimens. The World Health Organization reports over 1.7 billion annual cases of enteric diseases, with wealthier regions seeing a marked increase in inflammatory conditions [1]Source: World Health Organisation, "Diarrhoeal disease", www.who.int. With a growing number of individuals facing Irritable Bowel Syndrome, Gastroesophageal Reflux Disease, and lactose intolerance, the consumption of digestive supplements is on the rise. The National Institute of Diabetes and Digestive and Kidney Diseases notes that around 60 to 70 million Americans grapple with digestive diseases each year [2]Source: National Institute of Diabetes and Digestive and Kidney Diseases, "Digestive Statistics for the United States", niddk.nih.gov. Pharmaceutical giants, like Nestlé Health Science, are lending credibility to this sector, evidenced by their recent acquisition of Vowst. This is a pivotal move, as Vowst boasts the distinction of being the first FDA-approved oral microbiota therapy for recurrent C. difficile infections. With clinical evidence backing them, certain strains are swaying consumer preferences, moving them from casual trials to targeted treatments. This evolution not only ensures a steady demand—resilient even during economic slumps—but also opens avenues for premium pricing on scientifically validated products, elevating the market's value beyond mere volume growth.
Increasing consumer awareness of the microbiome–immune axis drives demand
Research underscores the gut's crucial role in immune health, prompting consumers to gravitate towards specific probiotic strains. Studies highlight how Akkermansia muciniphila strengthens gut barriers, curbs inflammation, and boosts metabolic health, driving the surge in demand for these specialized probiotics. This growing awareness of the gut microbiome's impact on overall health has led to increased interest in targeted interventions that address specific health concerns. In a shift post-pandemic, consumers are now placing a premium on preventive health measures rather than reactive treatments, as they aim to maintain long-term wellness and resilience against potential health challenges. Digital innovations, like Dieta Health's stool-imaging app, are adeptly converting biomarker data into personalized product suggestions, empowering consumers to make informed choices. These advancements in technology are bridging the gap between scientific insights and consumer accessibility, enabling individuals to better understand their unique health needs. As a result, there's a marked tilt towards supplements targeting specific health issues, with consumers favoring tailored solutions over one-size-fits-all alternatives.
Integration of digestive supplements into daily nutritional regimens drives growth
Consumers in developed markets are increasingly integrating digestive aids into their daily routines, blurring the lines between traditional supplements and functional foods. This trend is further fueled by innovative formats: sugar-free gummies and flavored powders enhance user adherence through their convenience and palatable taste, while prebiotic sodas elevate digestive ingredients to the forefront of mainstream beverages, appealing to health-conscious individuals seeking both health benefits and enjoyable consumption experiences. Additionally, the growing awareness of gut health's impact on overall well-being has driven demand for these products, encouraging manufacturers to invest in research and development for more effective and appealing solutions. As the digestive health supplements market merges with packaged foods, it broadens its distribution channels, spanning grocery stores to online platforms, and fortifies itself against seasonal demand shifts, ensuring steady market performance year-round.
Enhanced digestive health awareness through digital media platforms adds to its growth
Social media algorithms are increasingly favoring gut-health content, leading to viral loops that enhance understanding of the category through peer stories and expert insights. These algorithms amplify the visibility of gut-health discussions, making it easier for consumers to access and engage with relevant information. Discussions on TikTok have notably heightened searches for gummy formulations, particularly among Gen Z, who are drawn to convenient and palatable supplement options. This demographic's preference for innovative and easy-to-consume products has driven brands to focus on gummy supplements as a key growth area. Capitalizing on this trend, virtual-first providers such as Oshi Health are merging tele-consultations with tailored product bundles. This approach not only addresses consumer demand for personalized solutions but also broadens the reach of digestive health supplements beyond traditional brick-and-mortar stores, tapping into the growing preference for online health services and subscription-based models.
Restraints Impact Analysis
Restraint | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Stringent labelling and novel-food approval delays for synbiotic blends hinder growth | -0.8% | EU primary, with regulatory spillover to other markets | Medium term (2-4 years) |
Adulteration and potency degradation during supply chain affecting brand trust | -0.6% | Global, with concentration in cost-sensitive segments | Short term (≤ 2 years) |
Price sensitivity limiting premium supplement uptake | -0.4% | Emerging markets, with selective impact in developed economies | Medium term (2-4 years) |
Competition from alternative natural remedies affects growth | -0.3% | Global, With traditional medicine strongholds in Asia-Pacific | Long term (≥ 4 years) |
Source: Mordor Intelligence
Stringent labelling and novel-food approval delays for synbiotic blends hinders growth
Europe's Novel Foods Regulation requires detailed dossiers for botanical ingredients, but interpretations vary across member states. Gaining approval for multi-strain, multi-fiber synbiotics can take over 18 months, inflating development costs and postponing product launches. The complexity of the approval process, which involves rigorous safety assessments and compliance with varying national standards, further exacerbates these delays. Smaller companies find it challenging to finance these lengthy compliance processes, giving larger firms with seasoned regulatory teams a competitive edge. National actions, like Denmark's restrictions on ashwagandha, highlight how local decisions can override EU-wide approvals, necessitating region-specific reformulations that compromise economies of scale. These reformulations often require additional investment in research and development, further straining resources for smaller players.
Adulteration and potency degradation during supply chain affecting brand trust
Laboratory audits revealing underdosed products have shaken consumer confidence in the supply chain. Testing by NOW Foods found several berberine brands delivering less than 40% of their claimed active ingredients, raising concerns about product efficacy and transparency. Parallel audits of bromelain products noted even lower active levels, further highlighting inconsistencies in product quality. In response to these lapses, the FDA has ramped up inspections of foreign facilities, making unannounced visits to manufacturers in China and India. These inspections aim to bolster supply chain integrity by identifying and addressing non-compliance issues. However, they also lead to short-term disruptions, particularly for facilities that fail to meet regulatory standards and face subsequent actions. Such revelations have intensified calls for more stringent third-party verifications in the digestive health supplements market. These measures are seen as essential to restoring consumer trust and ensuring product quality. Additionally, compliant brands are being urged to prominently showcase their quality seals as a way to differentiate themselves in a competitive market.
Segment Analysis
By Type: Probiotics Dominate Despite Enzyme Acceleration
In 2024, probiotics dominated the market, capturing 82.12% of the revenue. This highlights years of strain-specific research and growing consumer trust. Strong evidence supporting probiotics' efficacy has driven their widespread adoption for digestive health. Enzymes, projected to grow at a 7.45% CAGR through 2030, are gaining traction due to rising demand for solutions addressing lactose intolerance and pancreatic insufficiency. These enzymes cater to specific health needs, appealing to health-conscious consumers. The "Others" category now includes postbiotics and synbiotics, with Akkermansia muciniphila products receiving European Food Safety Authority approval in 2024. Such advancements are reshaping the digestive health supplements market, focusing on clinically validated solutions to meet emerging consumer demands.
With clinical backing, enzymes command premium prices and have established a presence in practitioner channels, where healthcare professionals recommend them. Probiotics are diversifying into age-specific and mood-enhancing formats, addressing mental well-being alongside digestive health. Manufacturers are investing in heat-stable strains, expanding their use into gummies and baked goods, thus entering the functional foods market. New entrants in the postbiotic sector emphasize shelf stability and immune benefits, reflecting the evolving competitive landscape. These innovations are expected to drive differentiation and growth as companies meet the rising demand for advanced, science-backed solutions.

Note: Segment shares of all individual segments available upon report purchase
By Form: Gummies Transform Compliance, Capsules Keep Scale
In 2024, capsules and soft gels held a 47.43% market share, remaining the top choice for high-dose actives due to precise dosage delivery and protection of sensitive ingredients. Gummies and chewables are growing at a 7.21% CAGR through 2030, driven by better taste, vegan pectin systems, and starch-free production lines that lower costs and increase accessibility. Tablets are declining as consumers prefer convenient formats, while powders are gaining traction among sports nutrition enthusiasts and clinics for their customizable, high-performance formulations. New entrants like liquid-filled gummies and sublingual films are enhancing bioavailability and carving unique positions in the digestive health supplements market.
Consumers increasingly view gummies as snacks rather than medicinal products, boosting daily adherence and appealing to a wider age demographic, including children and older adults. Brands are tapping into this trend, using natural colors, sugar-free sweeteners, and recyclable jars to meet clean-label demands and align with sustainability goals. On the other hand, capsules continue to be favored by those who prioritize science, valuing controlled dosages and advanced technologies, such as delayed-release mechanisms, that ensure strain survival against stomach acid and improve efficacy.
By Distribution Channel: E-commerce Redefines Access
In 2024, specialty and health stores captured 36.23% of global revenue by leveraging expert staff and curated product assortments. These stores attract health-conscious shoppers seeking tailored advice and premium offerings. Online retailers, benefiting from search convenience, peer reviews, and swift shipping, are projected to grow at an 8.51% CAGR through 2030. The rise of e-commerce, mobile commerce, and digital payment advancements is reshaping purchasing habits and driving online sales. Direct-to-consumer subscription models enhance lifetime value and data capture by ensuring consistent product access, fostering brand loyalty, and enabling brands to gather insights for product innovation in the digestive health supplement market.
Mass supermarkets and pharmacies cater to impulse buys and immediate needs, but omnichannel strategies are gaining prominence. Brands are adopting click-and-collect options, influencer partnerships, and educational webinars to ensure visibility across the shopper's journey. These strategies create a unified shopping experience across physical and digital channels, meeting evolving consumer expectations. Loyalty programs and personalized marketing campaigns further strengthen customer engagement. With cold-chain probiotics gaining popularity, efficient last-mile logistics are crucial to ensure product integrity and timely delivery. Investments in temperature-controlled supply chains and advanced tracking systems are becoming essential to meet growing demand.

Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America commands a dominant 42.44% share of the global revenue, bolstered by clear FDA guidelines that empower assertive health-claim messaging. Consumers in the region increasingly view supplements as essential preventive care. According to the Council for Responsible Nutrition Survey 2023, nearly 74% of adults in the United States reported using dietary supplements, including digestive supplements [3]Source: Council for Responsible Nutrition Survey, "2023 CBN Survey on Dietary Supplements", crnusa.org. Furthermore, insurance pilots reimbursing microbiome therapeutics could solidify this trend, strengthening the digestive health supplements market in this already mature territory.
The Middle East and Africa are on a rapid ascent, boasting the fastest CAGR of 8.62% through 2030. This growth is fueled by increasing disposable incomes, the expansion of pharmacy chains, and proactive government health initiatives like Saudi Arabia's Vision 2030. With a youthful demographic and a deep-rooted cultural affinity for herbal tonics, the region is primed for the adoption of modern probiotics and enzymes. To navigate the diverse regulatory landscape and seamlessly blend Western formulations with indigenous botanicals, multinationals are forging partnerships with local distributors, setting the stage for a robust penetration of the digestive health supplements market.
Europe's regulatory environment offers both opportunities and challenges. EU-wide harmonization eases market access, but varying national interpretations create compliance hurdles. Sustainability mandates are driving a shift to organic ingredients and recyclable packaging. While consumers cautiously evaluate scientific evidence, they are willing to invest in proven products. In Asia-Pacific, traditional remedies merge with modern science, driving rapid adoption. China's regulatory framework accelerates imports via cross-border e-commerce while supporting domestic innovation. Urbanization and dietary shifts toward high-protein, low-fiber diets are boosting demand for tailored digestive solutions. Personalized nutrition services, integrating genetic and microbiome insights, further enhance the market's growth.

Competitive Landscape
The digestive health supplements market exhibits moderate fragmentation. Leadership is spread out, enabling specialized entrants to carve out niches using novel strains, advanced delivery technologies, and personalized programs. Acquisitions in the sector tend to focus on enhancing complementary capabilities rather than seeking direct overlaps. For instance, in June 2025, Danone bolstered its biotics portfolio by acquiring The Akkermansia Company, bringing in a clinically validated strain. Similarly, ADM expanded its foothold in practitioner channels with a GBP 185 million acquisition of Probiotics International.
Technology is carving out a significant niche in this market. In March 2025, Cylinder's acquisition of Dieta Health brought AI-driven stool-imaging diagnostics into the fold, allowing for immediate feedback on treatment efficacy and personalized recommendations. While larger players leverage their e-commerce platforms to amplify these digital services, start-ups are finding success with subscription models, offering microbiome sequencing kits and app-based coaching. Another competitive front is supply-chain transparency; companies are increasingly using blockchain tracking to validate strain viability and origin, addressing consumer concerns stemming from periodic potency scandals.
Agility is key in navigating the swift currents of innovation cycles and evolving regulations, particularly in Europe. To adeptly guide synbiotic blends through the stringent Novel Foods pathway, companies are establishing dedicated regulatory affairs teams. Early approvals not only command a pricing premium but also ensure shelf exclusivity, creating a self-reinforcing loop that fuels further investment in clinical trials. In a sign of the market's evolution, traditional pharmaceutical giants are beginning to bundle microbiome therapeutics with standard over-the-counter digestive solutions, hinting at a deeper integration within the digestive health supplements arena.
Digestive Health Supplements Industry Leaders
-
Bayer AG
-
Herbalife Nutrition Ltd.
-
Nestlé SA
-
Glanbia plc
-
Abbott Laboratories Inc
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- June 2025: Bioma launched its flagship product, Bioma Probiotics, a synbiotic supplement supporting gut health, immunity, and mental clarity. The vegan, non-GMO, shelf-stable capsules contain over 40 billion CFUs from 11 probiotic strains, inulin prebiotics, and a butyrate-based postbiotic complex, delivered through delayed-release DRcaps for intestinal targeting.
- March 2025: Inner Brightness introduced Akkermansia Probiotic, a digestive health supplement that combines pasteurized Akkermansia muciniphila (AKK PROBIO), DigeSEB broad-spectrum digestive enzymes, and B-complex vitamins. The AKK PROBIO strain has received self-affirmed GRAS (Generally Recognized as Safe) status as one of the first heat-inactivated probiotics.
- March 2025: TopGum developed Gummiotics, a sugar-free synbiotic gummy for gut health and immune support. Each 3g mandarin-shaped gummy features a patent-pending prebiotic fiber matrix containing 1 billion CFUs of Bacillus subtilis (DE111) probiotic and 34 mg of Bifidobacterium animalis subsp. lactis (BPL1) postbiotic.
- August 2024: Organic India introduced two certified organic gummy supplements in glass jars: Fiber Gummies in strawberry flavor, providing up to 5 g of prebiotic fiber per serving with less than 1 g of sugar for gut health support, and Ashwagandha Gummies in lemon-lime flavor, containing 300 mg of KSM-66 ashwagandha extract for stress management. Both products are non-GMO Project verified and priced at USD 25.99 for a 60-count jar.
Global Digestive Health Supplements Market Report Scope
Digestive supplements are normally taken with meals for digestive purposes and because they claim to treat common forms of gut irritation, heartburn, and other ailments.
The digestive health supplement market is segmented by type, distribution channel, and geography. Based on type, the market is segmented into prebiotics, probiotics, enzymes, and other types. Based on the distribution channel, the market is segmented into supermarkets and hypermarkets, pharmacies and drugstores, online retailers, and other distribution channels. Based on geography, the study provides an analysis of the digestive health supplement market in emerging and established markets across the world, including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. For each segment, the market sizing and forecasts have been done on the basis of the value (in USD).
By Type | Prebiotics | ||
Probiotics | |||
Enzymes | |||
Botanicals | |||
Other Types | |||
By Form | Capsules and Softgels | ||
Tablets | |||
Gummies and Chewables | |||
Powders | |||
Other Forms | |||
By Distribution Channel | Supermarkets/Hypermarkets | ||
Specialty and Health Stores | |||
Online Retailers | |||
Other Distribution Channels | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Rest of North America | |||
Europe | Germany | ||
United Kingdom | |||
Italy | |||
France | |||
Spain | |||
Netherlands | |||
Poland | |||
Belgium | |||
Sweden | |||
Rest of Europe | |||
Asia-Pacific | China | ||
India | |||
Japan | |||
Australia | |||
Indonesia | |||
South Korea | |||
Thailand | |||
Singapore | |||
Rest of Asia-Pacific | |||
South America | Brazil | ||
Argentina | |||
Colombia | |||
Chile | |||
Peru | |||
Rest of South America | |||
Middle East and Africa | South Africa | ||
Saudi Arabia | |||
United Arab Emirates | |||
Nigeria | |||
Egypt | |||
Morocco | |||
Turkey | |||
Rest of Middle East and Africa |
Prebiotics |
Probiotics |
Enzymes |
Botanicals |
Other Types |
Capsules and Softgels |
Tablets |
Gummies and Chewables |
Powders |
Other Forms |
Supermarkets/Hypermarkets |
Specialty and Health Stores |
Online Retailers |
Other Distribution Channels |
North America | United States |
Canada | |
Mexico | |
Rest of North America | |
Europe | Germany |
United Kingdom | |
Italy | |
France | |
Spain | |
Netherlands | |
Poland | |
Belgium | |
Sweden | |
Rest of Europe | |
Asia-Pacific | China |
India | |
Japan | |
Australia | |
Indonesia | |
South Korea | |
Thailand | |
Singapore | |
Rest of Asia-Pacific | |
South America | Brazil |
Argentina | |
Colombia | |
Chile | |
Peru | |
Rest of South America | |
Middle East and Africa | South Africa |
Saudi Arabia | |
United Arab Emirates | |
Nigeria | |
Egypt | |
Morocco | |
Turkey | |
Rest of Middle East and Africa |
Key Questions Answered in the Report
What is the current value of the digestive health supplements market?
The digestive health supplements market size is valued at USD 10.86 billion in 2025.
Which segment holds the largest share of the digestive health supplements market?
Probiotics dominate with 82.12% of global revenue in 2024, supported by extensive clinical research.
Which region is growing fastest in the digestive health supplements market?
The Middle East and Africa is projected to grow at an 8.62% CAGR between 2025 and 2030.
Why are gummies gaining popularity in digestive health products?
Gummies offer palatable flavors, vegan pectin options and convenience, driving a 7.21% CAGR through 2030.
Page last updated on: July 6, 2025